Published on
KembaraXtra-Medicine- Actinomycosis


Actinomycosis is an indolent, slowly progressive bacterial infection caused by anaerobic or microaerophilic organisms of the genus Actinomyces. These bacteria normally colonize the mouth, gastrointestinal tract, and female genital tract and do not exist freely in the environment. Disease occurs only when there is disruption of normal mucosal barriers, allowing organisms to invade deeper tissues. Actinomycosis is characterized by painful abscess formation, dense soft tissue infiltration, and the development of draining sinus tracts.


Actinomycosis occurs worldwide but has become relatively rare, with an estimated incidence far lower than the historical rate of approximately 1 in 300,000 reported in the 1970s. Improved oral hygiene and widespread antibiotic use have contributed to this decline. Males are affected more frequently than females, with a ratio of approximately 3:1, and the disease can occur at any age, though it is most commonly seen in middle-aged adults.


Clinically, actinomycosis can involve almost any organ system, most often following local tissue injury or mucosal breach. The most common form is cervicofacial actinomycosis, accounting for about 60% of cases. This form typically arises in the setting of poor dental hygiene, recent dental procedures, or minor oral trauma. Patients may present with painful soft tissue swelling near the angle of the mandible, fever, weight loss, trismus, and draining sinus tracts or fistulas.


Thoracic actinomycosis usually results from aspiration of oral secretions containing Actinomyces species, particularly in patients with poor oral hygiene. Symptoms include fever, cough, weight loss, and pleuritic chest pain. The infection may extend beyond the lungs to involve the pleura, mediastinum, or chest wall, leading to complications such as empyema, pericarditis, chest wall sinus tracts, or tracheoesophageal fistulas.


Abdominal actinomycosis commonly follows gastrointestinal surgery, appendicitis, bowel perforation, or diverticulitis. It most often affects the ileocecal region and presents with abdominal pain, fever, weight loss, and sometimes a palpable mass. Extension to adjacent organs such as the liver can result in abscess formation and jaundice, and sinus tracts may extend to the abdominal wall. Pelvic actinomycosis may occur by contiguous spread, particularly in women, and has been associated with intrauterine device (IUD) use.


Actinomycosis is most frequently caused by Actinomyces israelii, though other species such as A. naeslundii, A. odontolyticus, A. viscosus, and A. meyeri may be involved. These organisms are gram-positive, filamentous, non–spore-forming rods. Infections are typically polymicrobial, often involving organisms such as Streptococcus, Eikenella corrodens, Bacteroides, Enterococcus, and Fusobacterium species. Predisposing factors include diabetes mellitus, malnutrition, immunosuppression, and chronic mucosal injury.


Diagnosis relies on isolating Actinomyces organisms in the appropriate clinical context. Specimens are obtained through abscess aspiration, sinus tract excision, or tissue biopsy and must be cultured under anaerobic conditions for at least 5 to 7 days, as growth is slow. A characteristic diagnostic feature is the presence of sulfur granules in pus or tissue specimens. These yellow granules represent dense colonies of Actinomyces and are diagnostic when identified microscopically, although they may take weeks to grow in culture.


Imaging studies are useful adjuncts to define the extent of disease and localize infection. Chest radiography and computed tomography (CT) scans of the head, chest, abdomen, or pelvis are commonly used depending on the suspected site of involvement. Imaging often reveals infiltrative masses that cross tissue planes, a hallmark of actinomycosis.


Treatment of actinomycosis requires prolonged antibiotic therapy and, in many cases, surgical intervention. Nonpharmacologic management includes incision and drainage of abscesses and excision of sinus tracts when indicated. Penicillin remains the treatment of choice. Initial therapy typically consists of intravenous penicillin or ampicillin for 4 to 6 weeks, followed by prolonged oral therapy with penicillin V for an additional 4 to 6 weeks or longer. In complicated cases, total treatment duration may extend to 6 to 12 months. For penicillin-allergic patients, alternatives include doxycycline, erythromycin, or clindamycin.


With appropriate treatment, the prognosis of actinomycosis is excellent. Untreated disease, however, may spread extensively to contiguous tissues while ignoring normal anatomic boundaries. Hematogenous spread is rare. Because relapse can occur if therapy is too short, long-term antibiotic treatment is essential. Referral to an infectious disease specialist is recommended when actinomycosis is suspected, and surgical consultation is often necessary for management of abscesses, sinus tracts, or necrotic tissue.


Important clinical considerations include the absence of person-to-person transmission and the fact that isolation of Actinomyces in an asymptomatic individual does not indicate disease. Pelvic actinomycosis should be considered in women with long-term IUD use, and central nervous system involvement, though uncommon, can occur in the form of brain abscesses.


Picture
0 Comments